Tune disclosed the Series B round on Sunday, the eve of the J.P. Morgan Healthcare Conference, which regularly features as a curtain-raising meeting for the biotechnology and pharmaceutical sectors.

In ge­net­ic med­i­cine, a drum­beat of lay­offs and pipeline cuts has re­placed the ex­cite­ment of just a few years ago, when fresh fi­nanc­ing rounds were … ...

The Calcutta High Court on Friday (February 7, 2025) rejected the West Bengal government’s appeal challenging the trial court’s life term till death sentence awarded to RG Kar hospital rape ...

On Thursday, CEO Deepinder Goyal announced in a letter to shareholders that Zomato will soon be known as Eternal Ltd., with the company's board approving the name change. Listen to Story Zomato ...

Zomato band kar diya kya? Mera refund pending hai”. Zomato CEO Deepinder Goyal recently announced that the board of directors has approved a resolution to rename the company Eternal Ltd.

Investors clearly appreciate the song Tune Therapeutics is singing, handing over $175 million in series B funds as the biotech takes its epigenetic silencing drug into the clinic. The funding has ...

NEW YORK – Tune Therapeutics on Sunday said it has raised more than $175 million in a Series B funding round, which it will use to support its epigenome-editing hepatitis B program and advance its ...

Stories from Greater Manchester on BBC Sounds. Manchester Arena Bomb: Stories of Hope Introducing Manchester Arena Bomb: Stories of Hope Katie Thistleton finds courage, hope and healing in survivors.

Acclaimed singer-songwriter and hindustani classical music Visharad holder, Shreya Karmakar, recently released her poignant single Kho Diya. Accompanied by a visually captivating music video, Kho Diya ...

The funding will accelerate the development of the company’s existing pipeline, currently anchored by Tune-401 – its clinical-stage epigenetic silencing drug for chronic Hepatitis B (HBV).